A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
Clinical trial NCT05280548 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05280548
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2026-05-22
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.